Evidence mapPaperPMID 42112356Full record

ReviewFrontiers in immunology2026

Mapping the immune environment: spatiotemporal dynamics in cardiovascular events.

Rasit Dinc, Nurittin Ardic

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rasit DincINVAMED Medical Innovation Institute, New York, NY, United States.
Nurittin ArdicMed-International UK Health Agency Ltd., Nuneaton, Warwickshire, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular disease remains a leading cause of global mortality despite advances in revascularization, pharmacotherapy, and risk stratification. Immune responses to cardiovascular damage are neither temporally linear nor spatially homogeneous; they evolve across overlapping phases and distinct anatomical compartments. Here, we propose a four-dimensional spatiotemporal framework to map immune dynamics in cardiovascular events. Temporally, responses progress from hyperacute thrombo-inflammatory activation to acute inflammation, resolution/repair, and chronic remodeling. Spatially, immune programs differentiate across the intravascular compartment, infarct/lesion core, peri-infarct border zone, distant myocardium, and device-tissue interface, each possessing distinct cellular composition, signaling pathways, and therapeutic sensitivities. By integrating molecular imaging, single-cell and spatial transcriptomics, serial biomarker profiling, and computational modeling, we demonstrate how immune activity can be resolved with increasing anatomical and temporal precision. Using neutrophil extracellular traps as a case study, we show how the same effector mechanism can exhibit different effects depending on the phase and microenvironment. Clinical trial experience with anti-inflammatory therapies further emphasizes the need to align target selection and treatment timing with the underlying immunological trajectories. A spatiotemporal approach transforms cardiovascular inflammation from a static risk factor into a measurable and potentially targetable dynamic, site-specific process. Including phase, anatomical niche, and immune phenotype in experimental design and clinical interpretation can improve precise immunomodulation and strengthen translational alignment in cardiovascular medicine.

Indexed as

Cardiovascular DiseasesAnimalsBiomarkersHumansInflammationSpatial TranscriptomicsBiomarkerscardiovascular inflammationimmune compartmentsmolecular imagingprecision immunomodulationspatial transcriptomicsspatiotemporal dynamics

Identifiers

PMID42112356
PMCPMC13149110

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.